Addressing these barriers would support wider adoption of comprehensive molecular testing in ovarian cancer. Newsletter. Stay ahead of policy, cost, ...

Zentalis Pharmaceuticals progresses with azenosertib in the DENALI trial for Cyclin E1-positive platinum-resistant ovarian cancer, aiming for FDA approval by 2026. Part 2a of the trial will determine ...

Ovarian cysts are common, affecting around one in ten women. But sometimes they can cause pain – especially when they burst. You can usually manage the pain at home.

Adaptive NK Cells Exhibit Tumor-Specific Immune Memory and Cytotoxicity in Ovarian Cancer. Cancer Immunology Research , 2025; DOI: 10.1158/2326-6066.CIR-24-0852 Cite This Page : ...